AMAG Pharmaceuticals Inc (AMAG)-医療機器分野:企業M&A・提携分析

◆英語タイトル:AMAG Pharmaceuticals Inc (AMAG) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011405
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AMAG Pharmaceuticals Inc (AMAG) is a biopharmaceutical company that develops and commercializes specialty pharmaceutical products. The company focuses on maternal health, anemia management and cancer supportive care. Its major products include Makena (hydroxyprogesterone caproate injection) to reduce the risk of preterm birth in women, Feraheme (ferumoxytol) for iron deficiency anemia in adult patients with chronic kidney disease and MuGard Oral Mucoadhesive for the management of oral mucositis and all types of oral wounds including aphthous ulcers/canker sores and traumatic ulcers. AMAG also provides services related to the collection, processing and storage of umbilical cord blood stem cell and cord tissue units. The company offers these products through direct sales and a network of distributors. It has presence in the US, Switzerland and the UK. AMAG is headquartered in Waltham, Massachusetts, the US.

AMAG Pharmaceuticals Inc (AMAG) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
AMAG Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
AMAG Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
AMAG Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
AMAG Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
AMAG Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
AMAG Pharmaceuticals Inc, Medical Equipment, Deal Details 11
Private Equity 11
MSMB Capital Management To Acquire AMAG Pharma 11
Access Pharma Enters Into Licensing Agreement With Amag Pharma For MuGard 12
Equity Offering 13
AMAG Pharma Raises USD230.9 Million in Public Offering of Shares 13
Amag Pharma Files Registration Statement For Public Offering Of Securities For Up To US$250 Million 15
Debt Offering 16
AMAG Pharma Prices Public Offering of 3.25% Notes Due 2022 for USD300 Million 16
AMAG Pharma Raises USD500 Million in Private Placement of 7.878% Notes Due 2023 18
Amag Pharma Completes Public Offering Of Notes Due 2019 For US$200 Million 19
Acquisition 21
AMAG Pharma Plans For Sale Of The Company 21
AMAG Pharmaceuticals Inc – Key Competitors 22
AMAG Pharmaceuticals Inc – Key Employees 23
AMAG Pharmaceuticals Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 27
Financial Announcements 27
Nov 02, 2017: AMAG Pharmaceuticals Announces Third Quarter 2017 Financial Results and Business Highlights 27
Aug 03, 2017: AMAG Pharmaceuticals Announces Second Quarter 2017 Financial Results and Provides Corporate Update 30
May 02, 2017: AMAG Pharmaceuticals Announces First Quarter 2017 Financial Results and Provides Corporate Update 34
Feb 14, 2017: AMAG Reports Fourth Quarter and Full Year 2016 Financial Results 36
Jan 09, 2017: AMAG Pharmaceuticals Provides Financial and Business Update 39
Nov 03, 2016: AMAG Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Corporate Update 41
Aug 09, 2016: AMAG Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update 43
May 03, 2016: AMAG Pharmaceuticals Reports First Quarter 2016 Financial Results 46
Feb 17, 2016: AMAG Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Financial Results 48
Jan 11, 2016: AMAG Pharmaceuticals Announces Preliminary 2015 Financial Results and Provides 2016 Financial Guidance 50
Corporate Communications 51
Aug 08, 2017: AMAG Pharmaceuticals Appoints Oscar Sanchez as Vice President of Quality 51
May 16, 2017: AMAG Pharmaceuticals Appoints Helen Milton, Ph.D. as Vice President of Regulatory Affairs 52
Apr 25, 2017: AMAG Pharmaceuticals Appoints Arpad Simon, M.D. as Vice President of Pharmacovigilance 53
Mar 06, 2017: AMAG Announces Management Changes and New Commercial Appointments 54
Dec 21, 2016: AMAG Pharmaceuticals Announces Appointment of Brian Kelley to Board of Directors 55
Sep 07, 2016: AMAG Pharmaceuticals Appoints Tony Casciano as Senior Vice President of Hematology/Oncology Sales and Marketing 56
Jul 12, 2016: AMAG Pharmaceuticals Appoints Mark Stanton as Vice President, Market Access & Corporate Accounts 57
Apr 11, 2016: AMAG Pharmaceuticals Appoints Edward Myles as Chief Financial Officer 58
Jan 04, 2016: AMAG Pharmaceuticals Appoints Nicholas Grund as Chief Commercial Officer 59
Other Significant Developments 60
Jul 15, 2016: PhRMA Welcomes Five New Member Companies 60
Appendix 61
Methodology 61
About GlobalData 61
Contact Us 61
Disclaimer 61

List of Tables
AMAG Pharmaceuticals Inc, Medical Equipment, Key Facts, 2016 2
AMAG Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
AMAG Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
AMAG Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
AMAG Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
AMAG Pharmaceuticals Inc, Deals By Market, 2011 to YTD 2017 9
AMAG Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
MSMB Capital Management To Acquire AMAG Pharma 11
Access Pharma Enters Into Licensing Agreement With Amag Pharma For MuGard 12
AMAG Pharma Raises USD230.9 Million in Public Offering of Shares 13
Amag Pharma Files Registration Statement For Public Offering Of Securities For Up To US$250 Million 15
AMAG Pharma Prices Public Offering of 3.25% Notes Due 2022 for USD300 Million 16
AMAG Pharma Raises USD500 Million in Private Placement of 7.878% Notes Due 2023 18
Amag Pharma Completes Public Offering Of Notes Due 2019 For US$200 Million 19
AMAG Pharma Plans For Sale Of The Company 21
AMAG Pharmaceuticals Inc, Key Competitors 22
AMAG Pharmaceuticals Inc, Key Employees 23
AMAG Pharmaceuticals Inc, Other Locations 25
AMAG Pharmaceuticals Inc, Subsidiaries 25

★海外企業調査レポート[AMAG Pharmaceuticals Inc (AMAG)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cynvenio Biosystems Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cynvenio Biosystems Inc (Cynvenio) is a cancer diagnostic company that focuses on transforming cancer treatment and management through the molecular analysis of cancer biomarkers in blood. The company offers products such as lab automation systems, isolation products and proprietary informat …
  • Harland Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Harland Medical Systems Inc (Harland Medical) is a medical equipment provider that offers medical device coatings. The company offers test equipment, coating systems, laser equipment and dispensing equipment. Its products comprise lubricent UV hydrophilic coatings, bacticent antimicrobial co …
  • Xped Ltd (XPE):電力:M&Aディール及び事業提携情報
    Summary Xped Ltd (Xped) formerly Raya Group Limited, is an Internet of Things company that develops software and hardware solutions. It offers auto discovery remote control, Xerts, and Xped app software; and hardware such as Xped ADRC Shields, Umbo-Xped ADRC Hub, UltraPlug, VariPlug, IRBlaster. The …
  • Sandvine Corporation:企業の戦略的SWOT分析
    Sandvine Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • ProteinSimple-製薬・医療分野:企業M&A・提携分析
    Summary ProteinSimple, formerly Cell Biosciences Inc, a subsidiary of Bio Techne Corp, is a medical device company that offers protein analysis solutions. The company offers products such as simple plex systems, simple western systems, micro-flow imaging systems, cIEF and CE-SDS; gel documentation s …
  • Royal KPN N.V.:企業の戦略・SWOT・財務情報
    Royal KPN N.V. - Strategy, SWOT and Corporate Finance Report Summary Royal KPN N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Luna Innovations Inc (LUNA):企業の財務・戦略的SWOT分析
    Summary Luna Innovations Inc (Luna) is an optical technology development company that research, develops and commercializes speed optics and fiber optic test products. The company provides products such as fiber optic sensing products, fiber optic test and measurement products, high speed optical pr …
  • Hydro One Ltd (H):電力:M&Aディール及び事業提携情報
    Summary Hydro One Ltd (Hydro One) is a utility holding company that conducts electricity transmission and distribution in Ontario through its subsidiaries. It also undertakes telecommunications business and certain corporate activities. The company serves residential, commercial and industrial custo …
  • Imricor Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Imricor Medical Systems Inc (Imricor) is a medical device company that offers MRI equipments. The company offers products which include cardiac ablation systems, vision MR EP ablation catheter and horizon MR EP recording system. Its vision MR EP ablation catheter is used to operate in a MRI …
  • Myriad RBM Inc-医療機器分野:企業M&A・提携分析
    Summary Myriad RBM Inc (Myriad RBM), formerly Rules Based Medicine Inc, a subsidiary of Myriad Genetics Inc, is an immunoassay testing laboratory that provides protein biomarker products and services. The company’s products and services include HumanMAP services that assist investigators in the disc …
  • Interpace Diagnostics Group Inc (IDXG)-医療機器分野:企業M&A・提携分析
    Summary Interpace Diagnostics Group Inc (Interpace Diagnostics), formerly PDI Inc, is a developer of molecular diagnostics tests. The company offers PancraGen, a DNA based molecular test that aids in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its pathfinder platform; a …
  • ScanSource, Inc. (SCSC):企業の財務・戦略的SWOT分析
    ScanSource, Inc. (SCSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • LifeLabs Inc-医療機器分野:企業M&A・提携分析
    Summary LifeLabs Inc (LifeLabs) is a laboratory testing service provider that monitors heart disease and identifies neurological disorders and pinpoint allergies. The laboratory's services include clinical studies and services, drug and alcohol screening, employee wellness, hospital lab services, me …
  • Whirlpool Corp (WHR):企業の財務・戦略的SWOT分析
    Whirlpool Corp (WHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Hokkaido Gas Co Ltd (9534):企業の財務・戦略的SWOT分析
    Summary Hokkaido Gas Co Ltd (Hokkaido Gas), a subsidiary of Kita Gas Group is an oil and gas company that distributes petroleum products. The company’s business activities include gas business, heat supply, power supply, purification and sale of gas by-products, and production and sale of gas applia …
  • TenCate Advanced Armour:企業の戦略・SWOT・財務分析
    TenCate Advanced Armour - Strategy, SWOT and Corporate Finance Report Summary TenCate Advanced Armour - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Celina Insurance Group:企業の戦略・SWOT・財務分析
    Celina Insurance Group - Strategy, SWOT and Corporate Finance Report Summary Celina Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Coca-Cola HBC AG:企業の戦略・SWOT・財務情報
    Coca-Cola HBC AG - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola HBC AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Dermapharm AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Dermapharm AG (Dermapharm) is a pharmaceutical company that offers dermatological and allergy medicines. The company offers products for allergies, disinfection and wound treatment, skin and hair care, corticoids, minerals, osteoporosis, fungal infections, vaginal thrush, other preparations, …
  • Cremonini S.p.A. (Foodservice):企業の戦略・SWOT・財務情報
    Cremonini S.p.A. (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Cremonini S.p.A. (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆